Potential use of iontophoresis for transdermal delivery of NF-κB decoy oligonucleotides

International Journal of Pharmaceutics

Volumn 393, Issue 1-2, 2010, Pages 128-135

  Hashim, Irhan Ibrahim Abu ^a,b   Motoyama, Keiichi ^a   Abd ElGawad, Abd ElGawad Helmy ^b   El Shabouri, Mohamed H ^b   Borg, Thanaa Mohamed ^b   Arima, Hidetoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Iontophoresis; NF B decoy; Oligonucleotides; Skin inflammation; Transdermal delivery

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN DECOY OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; PHORBOL ESTER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG STABILITY; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IONTOPHORESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; SKIN PENETRATION; STRATUM CORNEUM; TISSUE DISTRIBUTION;

EID: 77953361779     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.04.020     Document Type: Article

References (55)

1. Anigbogu A., Patil S., Singh P., Liu P., Dinh S., Maibach H. An in vivo investigation of the rabbit skin responses to transdermal iontophoresis. Int. J. Pharm. 2000, 200:195-206.
2. Abramovits W. Atopic dermatitis. J. Am. Acad. Dermatol. 2005, 53:S86-93.
3. Aramaki Y., Arima H., Takahashi M., Miyazaki E., Sakamoto T., Tsuchiya S. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system. Biol. Pharm. Bull. 2003, 26:1461-1466.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Banga A.K., Chein Y.W. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Control. Release 1988, 8:1-24.
6. Banno T., Gazel A., Blumenberg M. Effects of tumor necrosis factor-α (TNFα) in epidermal keratinocytes revealed using global transcriptional profiling. J. Biol. Chem. 2004, 279:32633-32642.
7. Brand R.M., Iversen P.L. Iontophoretic delivery of a telomeric oligonucleotide. Pharm. Res. 1996, 13:851-854.
8. Brennan D.C., Jevnikar A.M., Takei F., Reubin-Kelley V.E. Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1. Kidney Int. 1990, 38:1039-1046.
9. Burnette R.R., Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 1987, 76:765-773.
10. Chang M.S., Chen B.C., Yu M.T., Sheu J.R., Chen T.F., Lin C.H. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-κB, but not p38 MAPK, pathways. Cell Signal 2005, 17:299-310.
11. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
12. Cooper K.D. Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 1994, 102:128-137.
13. Cullander C., Guy R.H. Visualization of iontophoretic pathways with confocal microscopy and the vibrating probe electrode. Solid States Ion 1992, 53:197-206.
14. De Rosa G., Maiuri M.C., Ungaro F., De Stefano D., Quaglia F., La Rotonda M.I., Carnuccio R. Enhanced intracellular uptake and inhibition of NF-κB activation by decoy oligonucleotide released from PLGA microspheres. J. Gene Med. 2005, 7:771-781.
15. Homey B., Steinhoff M., Ruzicka T., Leung D.Y. Cytokines and chemokines orchestrate atopic skin inflammation. J. Allergy Clin. Immunol. 2006, 118:178-189.
16. 14C]sodium diclofenac following iontophoresis and systemic administration in rabbits. J. Pharm. Sci. 2001, 90:1269-1276.
17. Isomura I., Morita A. Regulation of NF-κB signaling by decoy oligodeoxynucleotides. Microbiol. Immunol. 2006, 50:559-563.
18. Jacobsen J. Buccal iontophoretic delivery of atenolol HCl employing a new in vitro three-chamber permeation cell. J. Control. Release 2001, 70:83-95.
19. Kalia Y.N., Naik A., Garrison J., Guy R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 2004, 56:619-658.
20. Kang J.S., Youm J.K., Jeong S.K., Park B.D., Yoon W.K., Han M.H., Lee H., Han S.B., Lee K., Park S.K., Lee S.H., Yang K.H., Moon E.Y., Kim H.M. Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice. Int. Immunopharmacol. 2007, 7:1589-1597.
21. Kawamura I., Morishita R., Tomita N., Lacey E., Aketa M., Tsujimoto S., Manda T., Tomoi M., Kida I., Higaki J., Kaneda Y., Shimomura K., Ogihara T. Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model. Gene Ther. 1999, 6:91-97.
22. Kawamura I., Morishita R., Tsujimoto S., Manda T., Tomoi M., Tomita N., Goto T., Ogihara T., Kaneda Y. Intravenous injection of oligodeoxynucleotides to the NF-κB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther. 2001, 8:905-912.
23. Kigasawa K., Kajimoto K., Hama S., Saito A., Kanamura K., Kogure K. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Int. J. Pharm. 2010, 383:157-160.
24. Kubota T., Mctiernan C.F., Frye C.S., Demetris A.J., Feldman A.M. Cardiac-specific overexpression of tumor necrosis factor-α causes lethal myocarditis in transgenic mice. J. Card. Fail. 1997, 3:117-124.
25. Kumar M.G., Lin S. Transdermal iontophoresis: impact on skin integrity as evaluated by various methods. Crit. Rev. Ther. Drug Carrier Syst. 2008, 25:381-401.
26. Makarov S.S. NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Today 2000, 6:441-448.
27. Morishita R., Aoki M., Kaneda Y. Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?. Curr. Drug Targets 2000, 1:15-23.
28. Morishita R., Gibbons G.H., Ellison K.E., Nakajima M., Von Der Leyen H., Zhang L., Kaneda Y., Ogihara T., Dzau V.J. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest. 1994, 93:1458-1464.
29. Morishita R., Higaki J., Tomita N., Ogihara T. Application of transcription factor " decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ. Res. 1998, 82:1023-1028.
30. Morishita R., Sugimoto T., Aoki M., Kida I., Tomita N., Moriguchi A., Maeda K., Sawa Y., Kaneda Y., Higaki J., Ogihara T. In vivo transfection of cis element " decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat. Med. 1997, 3:894-899.
31. Nakamura H., Aoki M., Tamai K., Oishi M., Ogihara T., Kaneda Y., Morishita R. Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther. 2002, 9:1221-1229.
32. Nugroho A.K., Li G., Grossklaus A., Danhof M., Bouwstra J.A. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro. J. Control. Release 2004, 96:159-167.
33. Nugroho A.K., Li L., Dijkstra D., Wikstrom H., Danhof M., Bouwstra J.A. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro. J. Control. Release 2005, 103:393-403.
34. O'sullivan B.J., Thomas R. CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-κB. J. Immunol. 2002, 168:5491-5498.
35. Okabe K., Yamaguchi H., Kawai Y. New iontophoretic transdermal administration of the β-blocker metoprolol. J. Control. Release 1986, 4:79-85.
36. Pastore S., Fanales-Belasio E., Albanesi C., Chinni L.M., Giannetti A., Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J. Clin. Invest. 1997, 99:3009-3017.
37. Pikal M.J. The role of electroosmotic flow in transdermal and iontophoresis. Adv. Drug Deliv. Rev. 1992, 9:201-237.
38. Pizarro T.T., Malinowska K., Kovacs E.J., Clancy J., Robinson J.A., Piccinini L.A. Induction of TNF-α and TNF-β gene expression in rat cardiac transplants during allograft rejection. Transplantation 1993, 56:399-404.
39. Phipps J.B., Padmanabhan R.V., Lattin G.A. Iontophoretic delivery of model inorganic and drug ions. J. Pharm. Sci. 1989, 78:365-369.
40. Rudikoff D., Lebwohl M. Atopic dermatitis. Lancet 1998, 351:1715-1721.
41. Sakamoto T., Miyazaki E., Aramaki Y., Arima H., Takahashi M., Kato Y., Koga M., Tsuchiya S. Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice. Gene Ther. 2004, 11:317-324.
42. Santi P., Catellani P.L., Massimo G., Zanardi G., Colombo P. Iontophoretic transport of verapamil and melatonin I. Cellophane membrane as a barrier. Int. J. Pharm. 1993, 92:23-28.
43. Singh P., Maibach H.I. Iontophoresis in drug delivery: basic principles and applications. Crit. Rev. Ther. Drug Carrier Syst. 1994, 11:161-213.
44. Soter N.A. Morphology of atopic eczema. Allergy 1989, 44(Suppl. 9):16-19.
45. Tanaka A., Muto S., Jung K., Itai A., Matsuda H. Topical application with a new NF-κB inhibitor improves atopic dermatitis in NC/NgaTnd mice. J. Invest. Dermatol. 2007, 127:855-863.
46. Thysman S., Preat V., Roland M. Factors affecting iontophoretic mobility of metoprolol. J. Pharm. Sci. 1992, 81:670-675.
47. Tiwari S.B., Udupa N. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. Int. J. Pharm. 2003, 260:93-103.
48. Tomita N., Morishita R., Lan H.Y., Yamamoto K., Hashizume M., Notake M., Toyosawa K., Fujitani B., Mu W., Nikolic-Paterson D.J., Atkins R.C., Kaneda Y., Higaki J., Ogihara T. In vivo administration of a nuclear transcription factor-κB decoy suppresses experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2000, 11:1244-1252.
49. Tomita N., Morishita R., Tomita S., Yamamoto K., Aoki M., Matsushita H., Hayashi S., Higaki J., Ogihara T. Transcription factor decoy for nuclear factor-κB inhibits tumor necrosis factor-induced expression of interleukin-6 and intercellular adhesion molecule-1 in endotherial cells. Hypertension 1998, 16:993-1000.
50. Tomita T., Takeuchi E., Tomita N., Morishita R., Kaneko M., Yamamoto K., Nakase T., Seki H., Kato K., Kaneda Y., Ochi T. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 1999, 42:2532-2542.
51. Turner N.G., Ferry L., Price M., Cullander C., Guy R.H. Iontophoresis of poly-l-lysines: the role of molecular weight?. Pharm. Res. 1997, 14:1322-1331.
52. Uehara M., Izukura R., Sawai T. Blood eosinophilia in atopic dermatitis. Clin. Exp. Dermatol. 1990, 15:264-266.
53. Wearley L.L., Chien Y.W. Iontophoretic transdermal permeation of verapamil (III): effect of binding and concentration gradient on reversibility of skin permeation rate. Int. J. Pharm. 1990, 59:87-94.
54. Yoshimura S., Bondeson J., Foxwell B.M., Brennan F.M., Feldmann M. Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 2001, 13:675-683.
55. Zakzewski C.A., Amory D.W., Jasaitis D.K., Li J.K. Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive rabbits: preliminary report. Cardiovasc. Drugs Ther. 1992, 6:589-595.